Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP with Hydroxychloroquine for High-Risk Healthcare Workers
NCT04331834Phase 3Completed
- Sponsor
- Barcelona Institute for Global Health
- Start
- Apr 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Barcelona Institute for Global Health. Started Apr 2020; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04331834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04331834.